{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T14:30:34Z","timestamp":1784730634522,"version":"3.55.0"},"reference-count":190,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.biopha.2025.118205","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T09:43:58Z","timestamp":1748511838000},"page":"118205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["A systematic review of pharmaceutical targets in the mucosal immune system for treatment of non-intestinal auto-immune diseases"],"prefix":"10.1016","volume":"188","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1763-3122","authenticated-orcid":false,"given":"Boukje C.","family":"Eveleens Maarse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber D.","family":"Hofstede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon A.A.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthijs","family":"Moerland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118205_bib1","doi-asserted-by":"crossref","first-page":"6711","DOI":"10.1016\/j.vaccine.2014.08.089","article-title":"The mucosal immune system for vaccine development","volume":"32","author":"Lamichhane","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.biopha.2025.118205_bib2","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1007\/s11739-023-03329-1","article-title":"Role of mucosal immunity and epithelial-vascular barrier in modulating gut homeostasis","volume":"18","author":"Di Sabatino","year":"2023","journal-title":"Intern Emerg. Med."},{"key":"10.1016\/j.biopha.2025.118205_bib3","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"Holmgren","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2025.118205_bib4","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nri1203","article-title":"Plasma-cell homing","volume":"3","author":"Kunkel","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2025.118205_bib5","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/nrg.2015.33","article-title":"Autoimmune diseases - connecting risk alleles with molecular traits of the immune system","volume":"17","author":"Gutierrez-Arcelus","year":"2016","journal-title":"Nat. Rev. Genet"},{"key":"10.1016\/j.biopha.2025.118205_bib6","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/S0140-6736(23)00457-9","article-title":"Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK","volume":"401","author":"Conrad","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2025.118205_bib7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cell.2020.03.007","article-title":"Challenges, progress, and prospects of developing therapies to treat autoimmune diseases","volume":"181","author":"Fugger","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2025.118205_bib8","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41577-021-00583-2","article-title":"Mucosal vaccines - fortifying the frontiers","volume":"22","author":"Lavelle","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2025.118205_bib9","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/imm.13526","article-title":"Vaccines, adjuvants and key factors for mucosal immune response","volume":"167","author":"Correa","year":"2022","journal-title":"Immunology"},{"key":"10.1016\/j.biopha.2025.118205_bib10","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1053\/j.gastro.2015.01.007","article-title":"Diet in the pathogenesis and treatment of inflammatory bowel diseases","volume":"148","author":"Lee","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2025.118205_bib11","article-title":"The role of Akkermansia muciniphila in inflammatory bowel disease: current knowledge and perspectives","volume":"13","author":"Zheng","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2025.118205_bib12","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.pharmthera.2014.12.006","article-title":"The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy","volume":"149","author":"Cammarota","year":"2015","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.biopha.2025.118205_bib13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00281-017-0658-5","article-title":"Recipe for IBD: can we use food to control inflammatory bowel disease?","volume":"40","author":"Witkowski","year":"2018","journal-title":"Semin Immunopathol."},{"key":"10.1016\/j.biopha.2025.118205_bib14","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0162-3109(97)00090-8","article-title":"Immunosuppressive effect of budesonide on human lamina propria lymphocytes","volume":"38","author":"Elitsur","year":"1998","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.biopha.2025.118205_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314650","article-title":"Pathophysiology of type 1 diabetes and gut microbiota role","volume":"23","author":"Del Chierico","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118205_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/biom12030433","article-title":"Multiple sclerosis and microbiome","volume":"12","author":"Preiningerova","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2025.118205_bib17","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1007\/s00253-019-09770-7","article-title":"Targeting ideal oral vaccine vectors based on probiotics: a systematical view","volume":"103","author":"Jiang","year":"2019","journal-title":"Appl. Microbiol Biotechnol."},{"key":"10.1016\/j.biopha.2025.118205_bib18","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jclinepi.2021.03.001","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"134","author":"Page","year":"2021","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.biopha.2025.118205_bib19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst. Rev."},{"key":"10.1016\/j.biopha.2025.118205_bib20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0065-2776(09)01202-4","article-title":"How the immune system achieves self-nonself discrimination during adaptive immunity","volume":"102","author":"Jiang","year":"2009","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.biopha.2025.118205_bib21","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1365-2249.2008.03662.x","article-title":"Infiltration of forkhead box P3-expressing cells in small intestinal mucosa in coeliac disease but not in type 1 diabetes","volume":"152","author":"Tiittanen","year":"2008","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.biopha.2025.118205_bib22","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.2337\/diabetes.53.7.1680","article-title":"In vitro-deranged intestinal immune response to gliadin in type 1 diabetes","volume":"53","author":"Auricchio","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2025.118205_bib23","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/gut.30.7.955","article-title":"T-cell and plasma cell populations in coeliac small intestinal mucosa in relation to dermatitis herpetiformis","volume":"30","author":"Jenkins","year":"1989","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2025.118205_bib24","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6179243","article-title":"Celiac disease in children, particularly with accompanying type 1 diabetes, is characterized by substantial changes in the blood cytokine balance, which may reflect inflammatory processes in the small intestinal mucosa","volume":"2019","author":"Vorobjova","year":"2019","journal-title":"J. Immunol. Res"},{"key":"10.1016\/j.biopha.2025.118205_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10061227","article-title":"Gut microbiota and associated mucosal immune response in eosinophilic granulomatosis with polyangiitis (EGPA)","author":"Niccolai","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.biopha.2025.118205_bib26","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1136\/ard.60.5.495","article-title":"Flow cytometric analysis of gut mucosal lymphocytes supports an impaired Th1 cytokine profile in spondyloarthropathy","volume":"60","author":"Van Damme","year":"2001","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.biopha.2025.118205_bib27","first-page":"128","article-title":"P. Vahasalo. Increase of duodenal and ileal mucosal cytotoxic lymphocytes in juvenile idiopathic arthritis","volume":"28","author":"Arvonen","year":"2010","journal-title":"Clin. Exp. Rheuma"},{"key":"10.1016\/j.biopha.2025.118205_bib28","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1046\/j.1365-2249.2001.125002332.x","article-title":"Th2 dominance in nasal mucosa in patients with Wegener's granulomatosis","volume":"125","author":"Balding","year":"2001","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.biopha.2025.118205_bib29","article-title":"Immunological features of paranasal sinus mucosa in patients with graves' orbitopathy","volume":"11","author":"Lu","year":"2020","journal-title":"Front Endocrinol."},{"key":"10.1016\/j.biopha.2025.118205_bib30","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1212\/WNL.39.3.378","article-title":"Immune-reactive cells in multiple sclerosis mucosal secretions","volume":"39","author":"Coyle","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2025.118205_bib31","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1164\/ajrccm.156.2.9610076","article-title":"CD4-positive T-lymphocytes infiltrate the bronchial mucosa of patients with Sjogren's syndrome","volume":"156","author":"Papiris","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.biopha.2025.118205_bib32","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1681\/ASN.2021081086","article-title":"Galactose-deficient IgA1 B cells in the circulation of IgA nephropathy patients carry preferentially lambda light chains and mucosal homing receptors","volume":"33","author":"Zachova","year":"2022","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biopha.2025.118205_bib33","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/ndt\/gfaa264","article-title":"High levels of gut-homing immunoglobulin A+\u2009B lymphocytes support the pathogenic role of intestinal mucosal hyperresponsiveness in immunoglobulin A nephropathy patients","volume":"36","author":"Sallustio","year":"2021","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.biopha.2025.118205_bib34","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/ajd.12456","article-title":"The frequency of mucosal-associated invariant T cells is selectively increased in dermatitis herpetiformis","volume":"58","author":"Li","year":"2017","journal-title":"Austral J. Dermatol."},{"key":"10.1016\/j.biopha.2025.118205_bib35","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41514-024-00185-x","article-title":"An integrated single-cell atlas of blood immune cells in aging","volume":"10","author":"Filippov","year":"2024","journal-title":"NPJ Aging"},{"key":"10.1016\/j.biopha.2025.118205_bib36","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.3389\/fimmu.2020.01014","article-title":"MAIT Cell Activation and Functions","volume":"11","author":"Hinks","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2025.118205_bib37","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/ni.3298","article-title":"The burgeoning family of unconventional T cells","volume":"16","author":"Godfrey","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biopha.2025.118205_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010411","article-title":"Mucosal-Associated Invariant T (MAIT) cells are highly activated in duodenal tissue of humans with Vibrio cholerae O1 infection: a preliminary report","volume":"16","author":"Bhuiyan","year":"2022","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.biopha.2025.118205_bib39","doi-asserted-by":"crossref","DOI":"10.1111\/pim.12430","article-title":"Recent advances in gut immunology","volume":"39","author":"Powell","year":"2017","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.biopha.2025.118205_bib40","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/imm.13653","article-title":"Mucosal-associated invariant T cells in digestive tract: Local guardians or destroyers?","volume":"170","author":"Wang","year":"2023","journal-title":"Immunology"},{"key":"10.1016\/j.biopha.2025.118205_bib41","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41385-021-00469-5","article-title":"Mucosal-associated invariant T cells have therapeutic potential against ocular autoimmunity","volume":"15","author":"Yamana","year":"2022","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.biopha.2025.118205_bib42","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.3389\/fimmu.2019.02681","article-title":"A critical role for mucosal-associated invariant T cells as regulators and therapeutic targets in systemic lupus erythematosus","volume":"10","author":"Murayama","year":"2019","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2025.118205_bib43","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abe8931","article-title":"A subset of follicular helper-like MAIT cells can provide B cell help and support antibody production in the mucosa","volume":"7","author":"Jensen","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.biopha.2025.118205_bib44","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/ni.3854","article-title":"Cytotoxic and regulatory roles of mucosal-associated invariant T cells in type 1 diabetes","volume":"18","author":"Rouxel","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biopha.2025.118205_bib45","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/art.33314","article-title":"Mucosal-associated invariant T cells promote inflammation and exacerbate disease in murine models of arthritis","volume":"64","author":"Chiba","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.biopha.2025.118205_bib46","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.3389\/fimmu.2019.02690","article-title":"Mucosal-associated invariant T cell features and TCR repertoire characteristics during the course of multiple sclerosis","volume":"10","author":"Carnero Contentti","year":"2019","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2025.118205_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2016.03.014","article-title":"Neuropathologic, phenotypic and functional analyses of Mucosal Associated Invariant T cells in multiple sclerosis","volume":"166-167","author":"Salou","year":"2016","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.biopha.2025.118205_bib48","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/intimm\/dxr047","article-title":"Mucosal-associated invariant T cells regulate Th1 response in multiple sclerosis","volume":"23","author":"Miyazaki","year":"2011","journal-title":"Int Immunol."},{"key":"10.1016\/j.biopha.2025.118205_bib49","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1093\/brain\/awt182","article-title":"Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis","volume":"136","author":"Abrahamsson","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.biopha.2025.118205_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.890298","article-title":"Proinflammatory mucosal-associated invariant CD8+\u2009T cells react to gut flora yeasts and infiltrate multiple sclerosis brain","volume":"13","author":"Gargano","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2025.118205_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117335","article-title":"Altered CD161 bright CD8+\u2009mucosal associated invariant T (MAIT)-like cell dynamics and increased differentiation states among juvenile type 1 diabetics","volume":"10","author":"Harms","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2025.118205_bib52","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1007\/s00125-020-05257-7","article-title":"Mucosal-associated invariant T cell alterations during the development of human type 1 diabetes","volume":"63","author":"Gazali","year":"2020","journal-title":"Diabetologia"},{"issue":"8","key":"10.1016\/j.biopha.2025.118205_bib53","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.ajpath.2018.04.009","article-title":"No evidence for presence of mucosal-associated invariant T cells in the insulitic lesions in patients recently diagnosed with type 1 diabetes","volume":"188","author":"Kuric","year":"2018","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biopha.2025.118205_bib54","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1093\/rheumatology\/kez564","article-title":"Persistent deficiency of mucosal-associated invariant T cells during dermatomyositis","volume":"59","author":"Cassius","year":"2020","journal-title":"Rheumatol. (Oxf. )"},{"key":"10.1016\/j.biopha.2025.118205_bib55","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1038\/jid.2014.261","article-title":"The IL-17A-producing CD8+\u2009T-cell population in psoriatic lesional skin comprises mucosa-associated invariant T cells and conventional T cells","volume":"134","author":"Teunissen","year":"2014","journal-title":"J. Invest Dermatol."},{"key":"10.1016\/j.biopha.2025.118205_bib56","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1136\/annrheumdis-2015-208902","article-title":"IL-7 primes IL-17 in mucosal-associated invariant T (MAIT) cells, which contribute to the Th17-axis in ankylosing spondylitis","volume":"75","author":"Gracey","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.biopha.2025.118205_bib57","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fimmu.2018.01610","article-title":"P. Saas. Increased IL-22- and IL-17A-producing mucosal-associated invariant T cells in the peripheral blood of patients with ankylosing Spondylitis","volume":"9","author":"Toussirot","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2025.118205_bib58","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.3899\/jrheum.151133","article-title":"Involvement of mucosal-associated invariant T cells in ankylosing spondylitis","volume":"43","author":"Hayashi","year":"2016","journal-title":"J. Rheuma"},{"key":"10.1016\/j.biopha.2025.118205_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121124","article-title":"Mucosal-associated invariant T cell is a potential marker to distinguish fibromyalgia syndrome from arthritis","volume":"10","author":"Sugimoto","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2025.118205_bib60","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13075-018-1799-1","article-title":"Altered composition and phenotype of mucosal-associated invariant T cells in early untreated rheumatoid arthritis","volume":"21","author":"Koppejan","year":"2019","journal-title":"Arthritis Res Ther."},{"key":"10.1016\/j.biopha.2025.118205_bib61","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jaut.2016.03.015","article-title":"Persistent deficiency of circulating mucosal-associated invariant T (MAIT) cells in ANCA-associated vasculitis","volume":"70","author":"Braudeau","year":"2016","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.biopha.2025.118205_bib62","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13075-017-1257-5","article-title":"Activation status of mucosal-associated invariant T cells reflects disease activity and pathology of systemic lupus erythematosus","volume":"19","author":"Chiba","year":"2017","journal-title":"Arthritis Res Ther."},{"key":"10.1016\/j.biopha.2025.118205_bib63","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.4049\/jimmunol.1302701","article-title":"Mucosal-associated invariant T cell deficiency in systemic lupus erythematosus","volume":"193","author":"Cho","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2025.118205_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207149","article-title":"Low mucosal-associated invariant T-cell number in peripheral blood of patients with immune thrombocytopenia and their response to prednisolone","volume":"13","author":"Maekawa","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2025.118205_bib65","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1002\/eji.201646300","article-title":"Mucosal-associated invariant T cells are reduced and functionally immature in the peripheral blood of primary Sjogren's syndrome patients","volume":"46","author":"Wang","year":"2016","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.biopha.2025.118205_bib66","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/sji.12585","article-title":"Mucosal-associated invariant cells are deficient in systemic sclerosis","volume":"86","author":"Mekinian","year":"2017","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.biopha.2025.118205_bib67","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/cyto.b.22115","article-title":"Increased IFN-gamma(+) and TNF-alpha(+) mucosal-associated invariant T cells in patients with aplastic anemia","volume":"104","author":"Chen","year":"2023","journal-title":"Cytom. B Clin. Cytom."},{"key":"10.1016\/j.biopha.2025.118205_bib68","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1093\/rheumatology\/keaa054","article-title":"Association of mucosal-associated invariant T cells with different disease phases of polymyalgia rheumatica","volume":"59","author":"Nakajima","year":"2020","journal-title":"Rheumatol. (Oxf. )"},{"key":"10.1016\/j.biopha.2025.118205_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102652","article-title":"Mucosal-associated invariant T cells in giant cell arteritis","volume":"121","author":"Ghesquiere","year":"2021","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.biopha.2025.118205_bib70","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.3389\/fimmu.2018.01333","article-title":"Mucosal-associated invariant T cells in autoimmune diseases","volume":"9","author":"Chiba","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2025.118205_bib71","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/intimm\/dxab070","article-title":"Characteristics of mucosal-associated invariant T cells and their roles in immune diseases","volume":"33","author":"Chiba","year":"2021","journal-title":"Int Immunol."},{"key":"10.1016\/j.biopha.2025.118205_bib72","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/ni.3679","article-title":"Drugs and drug-like molecules can modulate the function of mucosal-associated invariant T cells","volume":"18","author":"Keller","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biopha.2025.118205_bib73","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25115895","article-title":"A comprehensive investigation of stimulatory agents on MAIT and Valpha7.2+\u2009\/CD161- T cell response and effects of immunomodulatory drugs","volume":"25","author":"Singh","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118205_bib74","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/819646","article-title":"Different pathological roles of toll-like receptor 9 on mucosal B cells and dendritic cells in murine IgA nephropathy","volume":"2011","author":"Kajiyama","year":"2011","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.biopha.2025.118205_bib75","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/art.41029","article-title":"Deletion of mucosa-associated lymphoid tissue lymphoma translocation protein 1 in mouse T cells protects against development of autoimmune arthritis but leads to spontaneous osteoporosis","volume":"71","author":"Gilis","year":"2019","journal-title":"Arthritis Rheuma"},{"key":"10.1016\/j.biopha.2025.118205_bib76","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/art.41204","article-title":"Requirement of mucosa-associated lymphoid tissue lymphoma translocation protein 1 protease activity for fcgamma receptor-induced arthritis, but not fcgamma receptor-mediated platelet elimination, in mice","volume":"72","author":"Martin","year":"2020","journal-title":"Arthritis Rheuma"},{"key":"10.1016\/j.biopha.2025.118205_bib77","article-title":"Mucosa-associated lymphoid tissue lymphoma translocation 1 as a novel therapeutic target for rheumatoid arthritis","volume":"7","author":"Lee","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118205_bib78","article-title":"Mucosa-associated lymphoid tissue lymphoma translocation protein 1 in rheumatoid arthritis: longitudinal change after treatment and correlation with treatment efficacy of tumor necrosis factor inhibitors","volume":"36","author":"Wang","year":"2022","journal-title":"J. Clin. Lab Anal."},{"key":"10.1016\/j.biopha.2025.118205_bib79","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/0022034513516345","article-title":"Type 1 diabetes-associated TLR responsiveness of oral epithelial cells","volume":"93","author":"Neiva","year":"2014","journal-title":"J. Dent. Res"},{"key":"10.1016\/j.biopha.2025.118205_bib80","article-title":"Role of Toll-Like Receptors in Neuroimmune Diseases: Therapeutic Targets and Problems","volume":"12","author":"Li","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2025.118205_bib81","first-page":"52","article-title":"Going, Toll-like receptors in skin inflammation and inflammatory diseases","volume":"20","author":"Kumar","year":"2021","journal-title":"EXCLI J."},{"key":"10.1016\/j.biopha.2025.118205_bib82","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.1021\/acs.jcim.4c00578","article-title":"Discovery of Novel Small Molecule Dual Inhibitor Targeting Toll-Like Receptors 7 and 9","volume":"64","author":"Haseeb","year":"2024","journal-title":"J. Chem. Inf. Model"},{"key":"10.1016\/j.biopha.2025.118205_bib83","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.15252\/embj.201488987","article-title":"Malt1 protease inactivation efficiently dampens immune responses but causes spontaneous autoimmunity","volume":"33","author":"Jaworski","year":"2014","journal-title":"EMBO J."},{"key":"10.1016\/j.biopha.2025.118205_bib84","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1111\/febs.13325","article-title":"MALT1--a universal soldier: multiple strategies to ensure NF-kappaB activation and target gene expression","volume":"282","author":"Afonina","year":"2015","journal-title":"FEBS J."},{"key":"10.1016\/j.biopha.2025.118205_bib85","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12964-024-01547-4","article-title":"Inhibition of the MALT1-LPCAT3 axis protects cartilage degeneration and osteoarthritis","volume":"22","author":"Kondreddy","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.biopha.2025.118205_bib86","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1158\/1535-7163.MCT-23-0518","article-title":"Inhibition of MALT1 and BCL2 induces synergistic antitumor activity in models of B-cell lymphoma","volume":"23","author":"Plotnik","year":"2024","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.biopha.2025.118205_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112383","article-title":"Discovery and preclinical evaluation of KYS202004A, a novel bispecific fusion protein targeting TNF-alpha and IL-17A, in autoimmune disease models","volume":"136","author":"Liu","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2025.118205_bib88","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00403-024-03122-w","article-title":"Effectiveness and safety of secukinumab updosing in patients with moderate to severe plaque psoriasis: data from the PURE registry","volume":"316","author":"Papp","year":"2024","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.biopha.2025.118205_bib89","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1007\/s13555-024-01188-y","article-title":"Ixekizumab demonstrates rapid and consistent efficacy for patients with psoriatic arthritis, regardless of psoriasis severity","volume":"14","author":"Armstrong","year":"2024","journal-title":"Dermatol. Ther. (Heide )"},{"key":"10.1016\/j.biopha.2025.118205_bib90","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12865-017-0189-9","article-title":"Association between IL-17 and IgA in the joints of patients with inflammatory arthropathies","volume":"18","author":"Elicabe","year":"2017","journal-title":"BMC Immunol."},{"key":"10.1016\/j.biopha.2025.118205_bib91","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1365-2249.2011.04510.x","article-title":"Up-regulation of small intestinal interleukin-17 immunity in untreated coeliac disease but not in potential coeliac disease or in type 1 diabetes","volume":"167","author":"Lahdenpera","year":"2012","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.biopha.2025.118205_bib92","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1002\/art.34355","article-title":"Interleukin-22 and interleukin-22-producing NKp44+\u2009natural killer cells in subclinical gut inflammation in ankylosing spondylitis","volume":"64","author":"Ciccia","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.biopha.2025.118205_bib93","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/rheumatology\/keac237","article-title":"In rheumatoid arthritis patients, total IgA1 and IgA2 levels are elevated: implications for the mucosal origin hypothesis","volume":"62","author":"Derksen","year":"2022","journal-title":"Rheumatol. (Oxf. )"},{"key":"10.1016\/j.biopha.2025.118205_bib94","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1021\/acs.jproteome.6b00598","article-title":"Proteome Analysis of Rheumatoid Arthritis Gut Mucosa","volume":"16","author":"Bennike","year":"2017","journal-title":"J. Proteome Res"},{"key":"10.1016\/j.biopha.2025.118205_bib95","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1002\/art.42549","article-title":"Rheumatoid Arthritis-Specific Autoimmunity in the Lung Before and at the Onset of Disease","volume":"75","author":"Joshua","year":"2023","journal-title":"Arthritis Rheuma"},{"key":"10.1016\/j.biopha.2025.118205_bib96","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13075-015-0690-6","article-title":"Rheumatoid arthritis-associated autoantibodies in non-rheumatoid arthritis patients with mucosal inflammation: a case-control study","volume":"17","author":"Janssen","year":"2015","journal-title":"Arthritis Re.s Ther."},{"key":"10.1016\/j.biopha.2025.118205_bib97","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/bjd.14410","article-title":"Serum and salivary IgG and IgA antibodies to desmoglein 3 in mucosal pemphigus vulgaris","volume":"175","author":"Ali","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.biopha.2025.118205_bib98","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1111\/bjd.14351","article-title":"Salivary IgA and IgG antibodies to bullous pemphigoid 180 noncollagenous domain 16a as diagnostic biomarkers in mucous membrane pemphigoid","volume":"174","author":"Ali","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.biopha.2025.118205_bib99","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1046\/j.1365-2133.1998.02168.x","article-title":"Mucous membrane pemphigoid: a dual circulating antibody response with IgG and IgA signifies a more severe and persistent disease","volume":"138","author":"Setterfield","year":"1998","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.biopha.2025.118205_bib100","doi-asserted-by":"crossref","first-page":"e4616","DOI":"10.1210\/clinem\/dgaa590","article-title":"Altered systemic and intestinal IgA immune responses in individuals with type 1 diabetes","volume":"105","author":"Huang","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2025.118205_bib101","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1055\/s-2002-33595","article-title":"Antibodies to bovine beta-casein in diabetes and other autoimmune diseases","volume":"34","author":"Monetini","year":"2002","journal-title":"Horm. Metab. Res"},{"key":"10.1016\/j.biopha.2025.118205_bib102","doi-asserted-by":"crossref","first-page":"366","DOI":"10.2340\/00015555-2849","article-title":"Ex vivo culture of duodenal biopsies from patients with dermatitis herpetiformis indicates that transglutaminase 3 antibody production occurs in the gut","volume":"98","author":"Hietikko","year":"2018","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.biopha.2025.118205_bib103","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2340\/00015555-1764","article-title":"Small bowel transglutaminase 2-specific IgA deposits in dermatitis herpetiformis","volume":"94","author":"Salmi","year":"2014","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.biopha.2025.118205_bib104","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/MCG.0000000000000533","article-title":"The decreasing prevalence of severe villous atrophy in dermatitis herpetiformis: a 45-year experience in 393 patients","volume":"51","author":"Mansikka","year":"2017","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.biopha.2025.118205_bib105","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1002\/art.40181","article-title":"Plasmablasts with a mucosal phenotype contribute to plasmacytosis in systemic lupus erythematosus","volume":"69","author":"Mei","year":"2017","journal-title":"Arthritis Rheuma"},{"key":"10.1016\/j.biopha.2025.118205_bib106","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1016\/S0140-6736(23)01460-5","article-title":"Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial","volume":"402","author":"Broome","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2025.118205_bib107","first-page":"1111","article-title":"Generation and characterization of a high affinity anti-human FcRn antibody, rozanolixizumab, and the effects of different molecular formats on the reduction of plasma IgG concentration","volume":"10","author":"Smith","year":"2018","journal-title":"MAbs"},{"key":"10.1016\/j.biopha.2025.118205_bib108","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.tim.2017.11.002","article-title":"Human gut microbiome: function matters","volume":"26","author":"Heintz-Buschart","year":"2018","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.biopha.2025.118205_bib109","first-page":"14","article-title":"Interaction between the gut microbiome and mucosal immune system","volume":"4","author":"Shi","year":"2017","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.biopha.2025.118205_bib110","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/imm.13037","article-title":"Impact of gut microbiota on gut-distal autoimmunity: a focus on T cells","volume":"156","author":"Sprouse","year":"2019","journal-title":"Immunology"},{"key":"10.1016\/j.biopha.2025.118205_bib111","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.4049\/jimmunol.1001443","article-title":"Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide A expression","volume":"185","author":"Ochoa-Reparaz","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2025.118205_bib112","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.2337\/db19-0211","article-title":"Polysaccharide a-dependent opposing effects of mucosal and systemic exposures to human gut commensal bacteroides fragilis in type 1 diabetes","volume":"68","author":"Sofi","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2025.118205_bib113","article-title":"Bifidobacterium animalis ssp. Lactis 420 mitigates autoimmune hepatitis through regulating intestinal barrier and liver immune cells","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2025.118205_bib114","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.3389\/fimmu.2020.02101","article-title":"Intestinal barrier breakdown and mucosal microbiota disturbance in neuromyelitis optical spectrum disorders","volume":"11","author":"Cui","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2025.118205_bib115","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1210\/jc.2016-3222","article-title":"Duodenal mucosa of patients with type 1 diabetes shows distinctive inflammatory profile and microbiota","volume":"102","author":"Pellegrini","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2025.118205_bib116","first-page":"574","article-title":"Gut microbiome dysbiosis and increased intestinal permeability in children with islet autoimmunity and type 1 diabetes: a prospective cohort study","volume":"20","author":"Harbison","year":"2019","journal-title":"Pedia Diabetes"},{"key":"10.1016\/j.biopha.2025.118205_bib117","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10787-997-0001-1","article-title":"Dietary therapy with Lactobacillus GG, bovine colostrum or bovine immune colostrum in patients with juvenile chronic arthritis: evaluation of effect on gut defence mechanisms","volume":"5","author":"Malin","year":"1997","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.biopha.2025.118205_bib118","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0091-6749(97)70093-9","article-title":"Probiotics: a novel approach in the management of food allergy","volume":"99","author":"Majamaa","year":"1997","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.biopha.2025.118205_bib119","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4161\/gmic.25487","article-title":"Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut","volume":"4","author":"Groeger","year":"2013","journal-title":"Gut Microbes"},{"key":"10.1016\/j.biopha.2025.118205_bib120","doi-asserted-by":"crossref","first-page":"8274","DOI":"10.1039\/D2FO00477A","article-title":"Whole grain germinated brown rice regulates intestinal immune homeostasis and gastrointestinal hormones in type 2 diabetic patients-a randomized control trial","volume":"13","author":"Ding","year":"2022","journal-title":"Food Funct."},{"key":"10.1016\/j.biopha.2025.118205_bib121","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1002\/art.42616","article-title":"Alteration of Gut Microbiota in Individuals at High-Risk for Rheumatoid Arthritis Associated With Disturbed Metabolome and the Initiation of Arthritis Through the Triggering of Mucosal Immunity Imbalance","volume":"75","author":"Luo","year":"2023","journal-title":"Arthritis Rheuma"},{"key":"10.1016\/j.biopha.2025.118205_bib122","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017366","article-title":"Effect of hookworm infection on wheat challenge in celiac disease--a randomised double-blinded placebo controlled trial","volume":"6","author":"Daveson","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2025.118205_bib123","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1017\/S0007114516004086","article-title":"Host-microbiome interactions in human type 2 diabetes following prebiotic fibre (galacto-oligosaccharide) intake","volume":"116","author":"Pedersen","year":"2016","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.biopha.2025.118205_bib124","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1081-1206(10)60596-0","article-title":"Effect of Lactobacillus rhamnosus GG on rBet v1 and rMal d1 specific IgA in the saliva of patients with birch pollen allergy","volume":"100","author":"Piirainen","year":"2008","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.biopha.2025.118205_bib125","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jaut.2018.10.005","article-title":"Changes in the composition of the upper respiratory tract microbial community in granulomatosis with polyangiitis","volume":"97","author":"Lamprecht","year":"2019","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.biopha.2025.118205_bib126","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/mi.2011.9","article-title":"Molecular signatures of a disturbed nasal barrier function in the primary tissue of Wegener's granulomatosis","volume":"4","author":"Laudien","year":"2011","journal-title":"Mucosal Immunol."},{"issue":"111","key":"10.1016\/j.biopha.2025.118205_bib127","first-page":"40","article-title":"The presence of staphylococcal superantigens in nasal swabs and correlation with activity of granulomatosis with polyangiitis in own material","volume":"36","author":"Fijolek","year":"2018","journal-title":"Clin. Exp. Rheuma"},{"key":"10.1016\/j.biopha.2025.118205_bib128","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s13075-016-1079-x","article-title":"Association between Staphylococcus aureus nasal carriage and disease phenotype in patients affected by systemic lupus erythematosus","volume":"18","author":"Conti","year":"2016","journal-title":"Arthritis Res Ther."},{"key":"10.1016\/j.biopha.2025.118205_bib129","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/ndt\/gfaa223","article-title":"Aberrant mucosal immunoreaction to tonsillar microbiota in immunoglobulin A nephropathy","volume":"36","author":"Yamaguchi","year":"2021","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.biopha.2025.118205_bib130","first-page":"685","article-title":"Intestinal barrier function","volume":"5","author":"Baumgart","year":"2002","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.biopha.2025.118205_bib131","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s12026-012-8308-4","article-title":"Mucosal immunology of tolerance and allergy in the gastrointestinal tract","volume":"54","author":"Steele","year":"2012","journal-title":"Immunol. Res."},{"key":"10.1016\/j.biopha.2025.118205_bib132","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.molmed.2008.03.001","article-title":"The immune privilege of the oral mucosa","volume":"14","author":"Novak","year":"2008","journal-title":"Trends Mol. Med"},{"key":"10.1016\/j.biopha.2025.118205_bib133","doi-asserted-by":"crossref","first-page":"899","DOI":"10.4049\/jimmunol.181.2.899","article-title":"Oral or nasal antigen induces regulatory T cells that suppress arthritis and proliferation of arthritogenic T cells in joint draining lymph nodes","volume":"181","author":"Broere","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2025.118205_bib134","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1196\/annals.1254.069","article-title":"Suppression of myasthenia gravis by antigen-specific mucosal tolerance and modulation of cytokines and costimulatory factors","volume":"998","author":"Souroujon","year":"2003","journal-title":"Ann. N. Y Acad. Sci."},{"key":"10.1016\/j.biopha.2025.118205_bib135","doi-asserted-by":"crossref","first-page":"5499","DOI":"10.4049\/jimmunol.174.9.5499","article-title":"Breakdown of mucosal immunity in the gut and resultant systemic sensitization by oral antigens in a murine model for systemic lupus erythematosus","volume":"174","author":"Akadegawa","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2025.118205_bib136","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2337\/diabetes.51.1.73","article-title":"Oral exposure to diabetes-promoting food or immunomodulators in neonates alters gut cytokines and diabetes","volume":"51","author":"Scott","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2025.118205_bib137","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1046\/j.1365-3083.2003.01248.x","article-title":"The cholera toxin B subunit is a mucosal adjuvant for oral tolerance induction in type 1 diabetes","volume":"57","author":"Bregenholt","year":"2003","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.biopha.2025.118205_bib138","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1002\/art.24916","article-title":"Epitope-specific immunotherapy of rheumatoid arthritis: clinical responsiveness occurs with immune deviation and relies on the expression of a cluster of molecules associated with T cell tolerance in a double-blind, placebo-controlled, pilot phase II trial","volume":"60","author":"Koffeman","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.biopha.2025.118205_bib139","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1172\/JCI118779","article-title":"Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients","volume":"98","author":"Fukaura","year":"1996","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.biopha.2025.118205_bib140","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/jama.2015.2928","article-title":"Effects of high-dose oral insulin on immune responses in children at high risk for type 1 diabetes: the Pre-POINT randomized clinical trial","volume":"313","author":"Bonifacio","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.biopha.2025.118205_bib141","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.2337\/diacare.27.10.2348","article-title":"Pancreatic beta-cell function and immune responses to insulin after administration of intranasal insulin to humans at risk for type 1 diabetes","volume":"27","author":"Harrison","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopha.2025.118205_bib142","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0952-7915(00)00166-7","article-title":"Antigen-specific therapy for autoimmune disease","volume":"12","author":"Harrison","year":"2000","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.biopha.2025.118205_bib143","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2337\/db10-1360","article-title":"Evidence that nasal insulin induces immune tolerance to insulin in adults with autoimmune diabetes","volume":"60","author":"Fourlanos","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2025.118205_bib144","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.semarthrit.2018.09.008","article-title":"Therapeutic tolerance in autoimmune disease","volume":"48","author":"Rayner","year":"2018","journal-title":"Semin Arthritis Rheum."},{"key":"10.1016\/j.biopha.2025.118205_bib145","doi-asserted-by":"crossref","first-page":"e565","DOI":"10.1016\/S2665-9913(20)30100-4","article-title":"Tolerance-inducing medicines in autoimmunity: rheumatology and beyond","volume":"2","author":"Stanway","year":"2020","journal-title":"Lancet Rheuma"},{"key":"10.1016\/j.biopha.2025.118205_bib146","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.2353\/ajpath.2008.080192","article-title":"Physiological, pathological, and therapeutic implications of zonulin-mediated intestinal barrier modulation: living life on the edge of the wall","volume":"173","author":"Fasano","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biopha.2025.118205_bib147","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1152\/physrev.00003.2008","article-title":"Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer","volume":"91","author":"Fasano","year":"2011","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.biopha.2025.118205_bib148","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1038\/s41467-020-15831-7","article-title":"Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis","volume":"11","author":"Tajik","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.118205_bib149","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106335","article-title":"Intestinal barrier dysfunction develops at the onset of experimental autoimmune encephalomyelitis, and can be induced by adoptive transfer of auto-reactive T cells","volume":"9","author":"Nouri","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2025.118205_bib150","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1136\/annrheumdis-2016-210000","article-title":"Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis","volume":"76","author":"Ciccia","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.biopha.2025.118205_bib151","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1159\/000324456","article-title":"Lower expression of tight junction protein 1 gene and increased FOXP3 expression in the small bowel mucosa in coeliac disease and associated type 1 diabetes mellitus","volume":"156","author":"Vorobjova","year":"2011","journal-title":"Int Arch. Allergy Immunol."},{"key":"10.1016\/j.biopha.2025.118205_bib152","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/cmi.2010.66","article-title":"Celiac disease in patients with type 1 diabetes: a condition with distinct changes in intestinal immunity?","volume":"8","author":"Uibo","year":"2011","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.biopha.2025.118205_bib153","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1111\/1346-8138.14647","article-title":"Intestinal barrier integrity in patients with plaque psoriasis","volume":"45","author":"Sikora","year":"2018","journal-title":"J. Dermatol."},{"key":"10.1016\/j.biopha.2025.118205_bib154","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1111\/jdv.15700","article-title":"Claudin-3 - a new intestinal integrity marker in patients with psoriasis: association with disease severity","volume":"33","author":"Sikora","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.biopha.2025.118205_bib155","first-page":"681","article-title":"Gut mucosal T cell lines from ankylosing spondylitis patients are enriched with alphaEbeta7 integrin","volume":"19","author":"Van Damme","year":"2001","journal-title":"Clin. Exp. Rheuma"},{"key":"10.1016\/j.biopha.2025.118205_bib156","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/030097498440831","article-title":"A. Tarkowski. Expression of the mucosal lymphocyte integrin alphaEbeta7 and its ligand E-cadherin in salivary glands of patients with Sjogren's syndrome","volume":"27","author":"Kroneld","year":"1998","journal-title":"Scand. J. Rheuma"},{"key":"10.1016\/j.biopha.2025.118205_bib157","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1046\/j.1365-2249.1999.00860.x","article-title":"Jejuna of patients with insulin-dependent diabetes mellitus (IDDM) show signs of immune activation","volume":"116","author":"Savilahti","year":"1999","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.biopha.2025.118205_bib158","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3109\/08916939209004829","article-title":"LFA-1 and ICAM-1 molecule expression in jejunal mucosa from children with autoimmune enteropathy","volume":"13","author":"Hill","year":"1992","journal-title":"Autoimmunity"},{"key":"10.1016\/j.biopha.2025.118205_bib159","doi-asserted-by":"crossref","first-page":"15140","DOI":"10.1073\/pnas.1814558116","article-title":"Loss of gut barrier integrity triggers activation of islet-reactive T cells and autoimmune diabetes","volume":"116","author":"Sorini","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2025.118205_bib160","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.125191","article-title":"Inflammatory arthritis disrupts gut resolution mechanisms, promoting barrier breakdown by Porphyromonas gingivalis","volume":"4","author":"Flak","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.biopha.2025.118205_bib161","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abq8476","article-title":"Oral mucosal breaks trigger anti-citrullinated bacterial and human protein antibody responses in rheumatoid arthritis","volume":"15","author":"Brewer","year":"2023","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.biopha.2025.118205_bib162","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0091-6749(96)80074-1","article-title":"Evaluation of the gut mucosal barrier: evidence for increased antigen transfer in children with atopic eczema","volume":"97","author":"Majamaa","year":"1996","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.biopha.2025.118205_bib163","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1007\/BF02100148","article-title":"Multiple sclerosis patients have peripheral blood CD45RO+\u2009B cells and increased intestinal permeability","volume":"41","author":"Yacyshyn","year":"1996","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.biopha.2025.118205_bib164","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/ecco-jcc\/jjy125","article-title":"Incidence of Arthritis\/Arthralgia in Inflammatory Bowel Disease with Long-term Vedolizumab Treatment: Post Hoc Analyses of the GEMINI Trials","volume":"13","author":"Feagan","year":"2019","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.biopha.2025.118205_bib165","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2016-211011","article-title":"Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel disease","volume":"76","author":"Orlando","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.biopha.2025.118205_bib166","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1201363","article-title":"Case report: Induction and maintenance of steroid-free remission with vedolizumab in a case of steroid-dependent autoimmune pancreatitis","volume":"14","author":"Griebel","year":"2023","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2025.118205_bib167","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1136\/annrheumdis-2016-210233","article-title":"An induction or flare of arthritis and\/or sacroiliitis by vedolizumab in inflammatory bowel disease: a case series","volume":"76","author":"Varkas","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.biopha.2025.118205_bib168","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF00918269","article-title":"Systemic immune response after mucosal immunization in patients with IgA nephropathy","volume":"12","author":"Waldo","year":"1992","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.biopha.2025.118205_bib169","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1146\/annurev-pharmtox-011613-135918","article-title":"The use of biomarkers in human pharmacology (Phase I) studies","volume":"55","author":"Cohen","year":"2015","journal-title":"Annu Rev. Pharm. Toxicol."},{"key":"10.1016\/j.biopha.2025.118205_bib170","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/cpt.2539","article-title":"OX40L Inhibition Suppresses KLH-driven Immune Responses in Healthy Volunteers: A Randomized Controlled Trial Demonstrating Proof-of-Pharmacology for KY1005","volume":"111","author":"Saghari","year":"2022","journal-title":"Clin. Pharm. Ther."},{"key":"10.1016\/j.biopha.2025.118205_bib171","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s12026-024-09484-7","article-title":"Immunomodulating effects of the single bacterial strain therapy EDP1815 on innate and adaptive immune challenge responses - a randomized, placebo-controlled clinical trial","volume":"72","author":"Eveleens Maarse","year":"2024","journal-title":"Immunol. Res"},{"key":"10.1016\/j.biopha.2025.118205_bib172","article-title":"Aberrant gut microbiome contributes to intestinal oxidative stress, barrier dysfunction, inflammation and systemic autoimmune responses in MRL\/lpr mice","volume":"12","author":"Wang","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2025.118205_bib173","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/cei.12587","article-title":"Gender bias in lupus: does immune response initiated in the gut mucosa have a role?","volume":"180","author":"Gaudreau","year":"2015","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.biopha.2025.118205_bib174","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1093\/rheumatology\/kes123","article-title":"Granulomatosis with polyangiitis involves sustained mucosal inflammation that is rich in B-cell survival factors and autoantigen","volume":"51","author":"Zhao","year":"2012","journal-title":"Rheumatol. (Oxf. )"},{"key":"10.1016\/j.biopha.2025.118205_bib175","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1365-2133.1988.tb03468.x","article-title":"Mast cells and IgE in intestinal mucosa in adult atopic dermatitis patients","volume":"119","author":"Kalimo","year":"1988","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.biopha.2025.118205_bib176","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/rheumatology\/35.3.218","article-title":"Adhesion of rheumatoid lymphocytes to mucosal endothelium: the gut revisited","volume":"35","author":"Kadioglu","year":"1996","journal-title":"Br. J. Rheuma"},{"key":"10.1016\/j.biopha.2025.118205_bib177","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1136\/ard.51.1.126","article-title":"Adhesion of rheumatoid peripheral blood and synovial fluid mononuclear cells to high endothelial venules of gut mucosa","volume":"51","author":"Kadioglu","year":"1992","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.biopha.2025.118205_bib178","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1136\/annrheumdis-2014-206323","article-title":"Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis","volume":"74","author":"Ciccia","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.biopha.2025.118205_bib179","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jcmgh.2020.04.014","article-title":"Interleukin 27 protects from gastric atrophy and metaplasia during chronic autoimmune gastritis","volume":"10","author":"Bockerstett","year":"2020","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2025.118205_bib180","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005516","article-title":"Cytotoxic Th1 and Th17 cells infiltrate the intestinal mucosa of Behcet patients and exhibit high levels of TNF-alpha in early phases of the disease","volume":"95","author":"Emmi","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.biopha.2025.118205_bib181","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/j.1365-4632.2009.04069.x","article-title":"Serum mucosa-associated epithelial chemokine (MEC\/CCL28) in atopic dermatitis: a specific marker for severity","volume":"48","author":"Ezzat","year":"2009","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.biopha.2025.118205_bib182","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.2337\/diabetes.52.9.2287","article-title":"Immunologic activity in the small intestinal mucosa of pediatric patients with type 1 diabetes","volume":"52","author":"Westerholm-Ormio","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2025.118205_bib183","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0272-6386(99)70141-1","article-title":"Exaggerated systemic antibody response to mucosal Helicobacter pylori infection in IgA nephropathy","volume":"33","author":"Barratt","year":"1999","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.biopha.2025.118205_bib184","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.imbio.2012.04.011","article-title":"Salivary IgA antibodies to cyclic citrullinated peptides (CCP) in rheumatoid arthritis","volume":"218","author":"Svard","year":"2013","journal-title":"Immunobiology"},{"key":"10.1016\/j.biopha.2025.118205_bib185","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1136\/annrheumdis-2018-213724","article-title":"Secretory form of rheumatoid arthritis-associated autoantibodies in serum are mainly of the IgM isotype, suggesting a continuous reactivation of autoantibody responses at mucosal surfaces","volume":"78","author":"van Delft","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2025.118205_bib186","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.33549\/physiolres.931498","article-title":"Anti-Helicobacter Pylori, anti-thyroid peroxidase, anti-thyroglobulin and anti-gastric parietal cells antibodies in Czech population","volume":"57","author":"Sterzl","year":"2008","journal-title":"Physiol. Res."},{"key":"10.1016\/j.biopha.2025.118205_bib187","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.3389\/fimmu.2018.01959","article-title":"Mucosal autoimmunity to cell-bound GP2 isoforms is a sensitive marker in PSC and associated with the clinical phenotype","volume":"9","author":"Sowa","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2025.118205_bib188","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1093\/ndt\/gfz249","article-title":"Systemic corticosteroids and mucosal-associated lymphoid tissue-targeted therapy in immunoglobulin A nephropathy: insight from the NEFIGAN study","volume":"35","author":"Coppo","year":"2020","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.biopha.2025.118205_bib189","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1365-2249.2012.04663.x","article-title":"Altered expression of intestinal human leucocyte antigen D-related and immune signalling molecules in juvenile idiopathic arthritis","volume":"170","author":"Arvonen","year":"2012","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.biopha.2025.118205_bib190","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3109\/03009740903390145","article-title":"Heat shock protein expression is low in intestinal mucosa in juvenile idiopathic arthritis: a defect in immunoregulation?","volume":"39","author":"Arvonen","year":"2010","journal-title":"Scand. J. Rheuma"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225003993?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225003993?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T15:53:46Z","timestamp":1758124426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225003993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":190,"alternative-id":["S0753332225003993"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118205","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review of pharmaceutical targets in the mucosal immune system for treatment of non-intestinal auto-immune diseases","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118205","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Centre for Human Drug Research. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118205"}}